Drugmaker Endo International said it won court approval for its bankruptcy plan to eliminate $5.5 billion in debt and resolve thousands of lawsuits related to its opioids and other products.
Drugmaker Endo International said it won court approval for its bankruptcy plan to eliminate $5.5 billion in debt and resolve thousands of lawsuits related to its opioids and other products.